ESTUDIO SUSTANCIAS ANTAGONISTAS PRODUCIDAS POR MICROORGANISMOS
ESTUDIO SUSTANCIAS ANTAGONISTA
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublikationen in Zusammenarbeit mit Forschern von Complexo Hospitalario Universitario de Santiago (9)
2023
-
Real-life validation of a sample pooling strategy for screening of hepatitis C
Clinical Microbiology and Infection, Vol. 29, Núm. 1, pp. 112.e1-112.e4
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Allium-based phytobiotic enhances egg production in laying hens through microbial composition changes in ileum and cecum
Animals, Vol. 11, Núm. 2, pp. 1-15
2020
2019
-
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)
Pharmacogenomics Journal
-
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients
Pharmacogenomics Journal, Vol. 19, Núm. 1, pp. 83-96
-
Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium
Scientific Reports, Vol. 9, Núm. 1
2017
-
Regulation of Fn14 receptor and NF-κB underlies inflammation in Meniere's disease
Frontiers in Immunology, Vol. 8, Núm. DEC